Addictions Therapeutics Market Report 2026

Addictions Therapeutics Market Overview

• Addictions Therapeutics market size has reached to $7.46 billion in 2025 • Expected to grow to $10.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Rising Alcohol Consumption Drives Growth In The Addiction Therapeutics Market • Market Trend: Innovative Breakthroughs In Addiction Therapeutics Market • North America was the largest region in 2025.

What Is Covered Under Addictions Therapeutics Market?

Addiction therapeutics refers to medication, treatment, and management of various forms of addiction to help individuals overcome substance use disorders (SUDs) and other forms of addiction. It involves group and individual therapy sessions to prevent substance misuse. The main addiction therapeutics include buprenorphine, naltrexone, bupropion, disulfiram, nicotine replacement products, varenicline, and others. Buprenorphine refers to a semi-synthetic narcotic analgesic that is given as C29H41NO4HCl as a dosage form and it is used to mimic the effects of opioid medicines to prevent withdrawal symptoms when an individual stops using them. The various treatment types are opioid addiction treatment, alcohol addiction treatment, nicotine addiction treatment, and other substance addiction treatment that are used in various treatment centers such as inpatient treatment centers, residential treatment centers, and outpatient treatment centers. These are distributed via different distribution channels such as hospital pharmacies, medical stores, and others that are applied in public, private, and government.

What Is The Addictions Therapeutics Market Growth Forecast?

The addictions therapeutics market size is expected to see strong growth in the next few years. It will grow to $10.24 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to development of novel addiction therapeutics, increasing government and private funding for suds programs, growth in telehealth and digital treatment platforms, rising integration of mental health and addiction therapies, expansion of public-private partnerships in addiction care. Major trends in the forecast period include rising demand for medication-assisted treatment (mat), expansion of inpatient and outpatient addiction treatment centers, increasing adoption of telehealth and remote counseling services, growing focus on nicotine and opioid addiction therapies, enhanced awareness programs for substance use disorders.

Global Addictions Therapeutics Market Segmentation

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs 2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment 3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center 4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel Subsegments: 1) By Buprenorphine: Subutex, Suboxone 2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol) 3) By Bupropion: Wellbutrin, Zyban 4) By Disulfiram: Antabuse, Generic Disulfiram 5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges 6) By Varenicline: Chantix (Champix), Generic Varenicline 7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

What Is The Driver Of The Addictions Therapeutics Market?

Increasing consumption of alcohol is expected to propel the growth of the addiction therapeutics market going forward. Alcohol consumption refers to the process of drinking beverages containing ethyl alcohol. Addiction therapeutics are used to treat addiction to alcohol, which encourages individuals to consume less alcohol by preventing the depressive effects of alcohol and promoting the balance between the excitatory and inhibitory neurotransmitters glutamate and gamma-aminobutyric acid in an individual, which reduces alcohol cravings and alleviates symptoms and suppresses symptoms such as insomnia, anxiety, and restlessness associated with alcohol withdrawal. For instance, in December 2024, according to the Kirin Holdings Co. Ltd., a Japan-based alcoholic and non-alcoholic beverage and pharmaceuticals product company, global beer consumption in 2023 saw a slight increase of approximately 200,000 kl compared to 2022, reaching around 187.9 million kl, equivalent to roughly 296.9 billion 633 ml bottles, marking a modest growth of 0.1% year-over-year. Therefore, increasing consumption of alcohol is propelling the addiction therapeutics market.

Key Players In The Global Addictions Therapeutics Market

Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Global Addictions Therapeutics Market Trends and Insights

Major companies operating in the addiction therapeutics market are developing innovative products such as drugs for cocaine use disorders (CUD) to meet larger customer bases, more sales, and increase revenue. Drugs for cocaine use disorders (CUD) are medications designed to help individuals who are struggling with cocaine addiction or dependence. For instance, in January 2023, Tempero Bio, a US-based biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) approval for the TMP-301. The distinguishing characteristic of TMP-301, the Company's investigational candidate, lies in its role as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Specifically tailored for a prominent role in treating cocaine use disorders (CUD), TMP-301 stands out for its potency, selectivity, and oral availability, all aimed at effectively curbing the overactive glutamate signaling associated with CUD.

What Are Latest Mergers And Acquisitions In The Addictions Therapeutics Market?

In March 2023, Indivior, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc for approximately $145 million. With this acquisition, Indivior aims to strengthen its portfolio in investigational opioid overdose therapy and boost its scientific research and addiction treatment portfolio. Opiant Pharmaceuticals Inc. is a US-based biopharmaceutical company offering medicines for addiction and drug overdose.

Regional Outlook

North America was the largest region in the addictions therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Addictions Therapeutics Market?

The addiction therapeutics market consists of revenues earned by entities by providing cognitive behavioral therapy, contingency management for addiction, rational emotive behavior therapy (REBT), motivational interviewing, family therapy for addiction, facilitation therapy for addiction, eye movement desensitization and reprocessing (EMDR), dialectical behavior therapy, matrix model for addiction and person-centered therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The addiction therapeutics market also includes sales of suboxone, methadone, naltrexone, antidepressants, and acamprosate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Addictions Therapeutics Market Report 2026?

The addictions therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the addictions therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.